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Strains of human immunodeficiency virus type 1 (HIV-1) differ significantly in both genetic content and biological properties.
One of the earliest discovered differences between HIV-1 strains was divergence in the relative ability of different strains
to replicate in either T-cell lines or monocytes/macrophages. This observation has led to the suggestion that molecules
present on the surface of HIV-susceptible cells other than CD4 may interact with gp120 in facilitating the entry of HIV-1
into host cell populations. Several reports have suggested that CD26, a cell surface protease expressed on many cells of
the immune system including some CD4/ T-cells and macrophage, may be an accessory molecule for HIV-1 entry. Recently,
it has also been reported that the expression of high levels of CD26 correlates with the entry and replication of macrophage-
tropic strains of HIV-1 in a T-cell line. In this report, we demonstrate that replication of macrophage-tropic strains of HIV-
1 in T-cell lines is independent of CD26 expression. From this observation, we conclude that CD26 plays no role in the
entry of HIV-1 into these cells. q 1996 Academic Press, Inc.
atic phase of AIDS progresses (Schuitemaker et al.,INTRODUCTION
1991).
Studies of the genetic basis of HIV-1 tropism haveIsolates of human immunodeficiency virus type 1 (HIV-
demonstrated that the third variable (V3) region of HIV-11) show a high degree of genetic diversity caused by a
envelope protein gp120 controls this ability (Bergeron ethigh rate of mutation due to reverse transcriptase, or
al., 1992; Carrillo et al., 1993; Hwang et al,, 1991; Okadapossibly RNA polymerase II, error. This results in the
et al., 1994; O’Brien et al., 1990; Chesebro et al., 1991,rapid evolution of variant HIV-1 strains with divergent
1992; Shoida et al., 1991, 1992; Stamatatos and Cheng-biological properties, such as resistance to antibody neu-
Mayer, 1995; Harrowe and Cheng-Mayer, 1995; Henkeltralization or resistance to anti-viral drugs. It is also clear
et al., 1995; Westervelt et al., 1991, 1992), but the mecha-that during the course of an infection, variants of HIV-1
nism by which V3 controls entry or replication has notcan arise that differ in their cellular tropism, though the
been determined. Several studies have focused on thereasons for this variation and its effects on disease pro-
possibility that a second molecule present on the surfacegression remain uncertain. This divergence has been
of the monocyte/macrophages may act as a coreceptormost studied in the differences between strains of HIV-
with CD4. Studies on the entry of HIV-1 in cells of the1 that are able to replicate in T-cell lines, but not in
nervous system identified Gal C as a candidate corecep-monocyte/macrophage cultures (T-cell tropic), and, con-
tor molecule (Harouse et al., 1991), and some studiesversely, those which replicate well in monocyte/macro-
have demonstrate binding of the V3 loop to Gal C (Yahiphage cultures, but are unable to replicate in most T-cell
et al., 1995). However, a study demonstrating the lack oflines (Mf-tropic). Clinically, Mf-tropic variants of HIV-1
binding by HIV-1 to oligodendrocytes, the main cell typeseem to dominate during the asymptomatic, seropositive
in the central nervous system (CNS) expressing Gal Cphase of the disease, with an increasing probability of
(see Raff, 1989, for review), suggests that Gal C does notthe appearance of T-cell tropic isolates as the symptom-
play a role in the infection of any cell type by HIV-1
(Parmantier et al., 1995). It has been noted that the V3
loops of most HIV-1 isolates contain several arginine1 To whom correspondence and reprint requests should be ad-
dressed. Fax. 301-496-8394. residues, which are cleavage sites for many proteases,
2 Current address: Laboratory of Molecular Virology, Center for Bio- and two proline residues, which are also protease cleav-
logics Evaluation and Research, U.S. Food and Drug Administration, age sites. This observation led to the suggestion that the
Rockville, MD 20852-1448.
V3 loop might be a target for proteolytic cleavage of3 Current address: Institute of Human Virology, Medical Biotechnol-
gp120 during virus entry (Gu et al., 1993). Cleavage ofogy Center, University of Maryland Biotechnology Institute, Baltimore,
MD 21021. envelope proteins during entry has been described for
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other viruses, most notably influenza (Klenk et al., 1975;
Zhirnov et al., 1982; Yewdell et al., 1983; Kawaoka and
Webster, 1988), where it is essential for the entry of the
viral core into the cell. Dipeptidyl peptidase IV or CD26
has been identified as a protease present on mature
macrophages and at least a subset of T4 lymphocytes
(Tanaka et al., 1992) and has been postulated as a possi-
ble coreceptor for HIV-1 (Callebaut et al., 1993). However,
this observation remains controversial because of the
inability of other laboratories to confirm the results (La-
zaro et al., 1994; Morimoto et al., 1994; Werner et al.,
1994; West and Stott, 1994; Stamatatos and Levy, 1994).
Some studies have even suggested that primary CD4//
CD260 lymphocytes are preferentially infected by HIV-1
(Blazquez et al., 1992).
Recently, studies on the replication of Mf-tropic
strains of HIV-1 in clones of PM1, a T-cell line that sup- FIG. 1. Expression of CD26 by Supt-1 (1), Hut78 (2), H9 (3), and PM-
1(4) cells as measured by FACSscan analysis. Sample 5 is a negativeports the growth of both T-cell tropic and Mf-tropic
control. Data are presented as histograms, plotting cell number (y axis)strains of HIV-1, have demonstrated that clones with low
versus fluorescence intensity (x axis). Determinations were conductedlevels of CD26 expression support replication of Mf-
twice with the same results.
tropic HIV-1 at lower levels. In addition, these studies
showed that CD26 expression by PM-1 cells is down-
regulated following infection by Mf-tropic, but not T-cell- each culture was assessed by p24 ELISA every 2–3
tropic strains of HIV-1 (Oravecz et al., 1995). These re- days, when the medium was changed and the cell num-
sults have been interpreted to suggest again that CD26 ber was reduced to approximately 2 1 106.
may play the role of cofactor to CD4 for the entry of
some HIV-1 strains into some cells. To investigate this FACS analysis
possibility, we examined the replication of T-cell-tropic
Expression of CD26 antigen on T-cell lines was ana-and Mf-tropic strains of HIV-1 in T-cell lines that differed
lyzed by staining 1 1 106 cells with phycoerythrin (PE)-in their expression of CD26. The replication of Mf-tropic
labeled mAbs against CD26, CD4, or irrelevant PE controlHIV-1 was restricted to two of the four cell lines, but not
(Immunotech, Westbrook, ME) for 30 min at 47. The cellsin a way that correlated with CD26 expression. In further
were then washed with PBS/1% FBS and resuspendedexperiments, we were unable to confirm the specific
in 500 ml PBS. Fluorocytometry was performed on a FAC-down-regulation of CD26 by Mf-tropic strains of HIV-1
Scan analyzer (Becton–Dickinson, San Jose, CA), usingreported by Oravecz et al. (1995) and conclude that CD26
appropriate gating to eliminate dead cells and debris.plays no role in determining the entry or replication of
HIV-1 in these T-cell lines.
RESULTS
METHODS AND MATERIALS Expression of CD26 by T-cell lines
Cell culture
We examined the expression of CD26 on 4 CD4/ T-
cell lines (H9, Supt-1, Hut78, and PM-1) by FACSscanCos-1 cells were cultured in DMEM supplemented
with 25 mg/ml gentamicin, 2 mM L-glutamine, and 10% analysis. The results of our analysis showed that two of
these cell lines were CD26/ (H9 and PM-1), while twoFBS, passaged, and subcultured by trypsinization using
standard techniques. T-cell lines H9, Hut78, Supt-1, and were CD260 (Hut78 and Supt-1) (Fig. 1). Expression of
CD26 by cell lines Hut78 and Supt-1 was consistentlyPM-1 (Lusso et al., 1995) were grown in RPMI 1640 me-
dium supplemented with 2 mM L-glutamine, 10% FBS, equal to the negative controls, and expression of CD26
by H9 cells was consistently seen in 100% of the cells.and 25 mg/ml gentamicin. Macrophages were purified
from PBLs by adhesion and maintained in RPMI 1640 Expression of CD26 by PM-1 was generally seen in be-
tween 95 and 100% of the cells tested; however, thissupplemented with 2 mM L-glutamine, 5% FBS, 5% human
AB serum, and 25 mg/ml gentamicin and GM-CSF, as percentage occasionally dropped to as little as 40% for
no apparent reason. The mean density of CD26 expres-previously described (Gartner et al., 1986a,b). Viral stocks
were titered by p24 ELISA; infections were performed sion on PM-1 and H9 was the same, at 340 molecules/
cell. From these data we conclude that cell line H9 wasusing a volume corresponding with 100 pg of p24 to
infect 1 1 106 cells, as previously described (Watkins et at least equal to cell line PM-1 in the expression of CD26,
while cell lines Hut78 and Supt-1 are completely negativeal., 1990). The presence of HIV-1 in the supernatant of
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vecz et al., 1995). Since we had already been unable to
demonstrate CD26 dependence of infection of T-cell
lines by Mf-tropic strains of HIV-1, we decided to also
examine the ability of Mf-tropic strains of HIV-1 to effi-
ciently down-regulate CD26 in these cells. We followed
the expression of CD26 in either uninfected PM-1 cells
or PM-1 cells infected with either T-cell-tropic or Mf-
tropic strains of HIV-1 by FACSscan analysis during the
course of an infection. The results of these experiments
indicated that CD26 expression fluctuated during the
course of the experiment in all cultures, declining from
around 90% at 3 days postinfection (dpi) to about 55% at
25 dpi (Fig. 4). In these experiments, fluctuation of CD26
expression was not related to infection by, or expression
of, HIV-1, since uninfected cells showed similar de-
FIG. 2. Expression of HIV-1Ba-L (black squares, dashed line) and
HIV-1HXB-2 (open circles, solid line) in primary macrophage cultures.
Determinations of HIV-1 expression were conducted in duplicate on
macrophage cultures from four different individuals. Representative
data are shown.
for CD26 expression. CD4 was expressed by 100% of the
cells in all four cell lines, with a mean density of between
380 and 650 molecules/cell.
Expression of macrophage-tropic and T-cell tropic
strains of HIV-1 in macrophage and T-cell lines
The ability of the strains of HIV-1 used in this study to
replicate in macrophage was examined and the results
of these experiments showed that HIV-1Ba-L was able to
replicate to high levels in macrophage, while HIV-1HXB-2
was not (Fig. 2).
To determine whether the expression of CD26 corre-
lated with the ability of T-cell lines to support the replica-
tion of Mf-tropic strains of HIV-1, we first looked at the
expression of HIV-1Ba-L and HIV-1HXB-2 in the four CD4
/
T-cell lines examined for CD26 expression. As expected,
HIV-1HXB-2 was able to replicate in all four cell lines (Fig.
3A). HIV-1Ba-L , however, was able to replicate only in cell
lines PM-1 and Supt-1 and in these cells at a significantly
lower level than HIV-1HXB-2 (Fig. 3B). When correlated with
the expression of CD26 (Fig. 1), it is clear that HIV-1Ba-L
is able to replicate in one CD26/ (PM-1) and one CD260
(Supt-1) cell line, but is also unable to replicate in one
CD26/ (H9) and one CD260 (Hut78) cell line, suggesting
that there is no correlation between CD26 expression by
a CD4/ T-cell line and the ability to support the replica-
tion of Mf-tropic strains of HIV-1.
Regulation of CD26 expression in PM-1 cells is not
influenced by infection with HIV-1 FIG. 3. Expression of HIV-1HXB-2 (A) and HIV-1Ba-L (B) in T-cell lines
H9 (open squares), Supt-1(solid triangles), Hut78 (open circles), andIn a previous report, it has been claimed that following
PM-1 (crosses). Infections were repeated three or more times in the
infection of PM-1 cells by Mf-tropic, but not T-cell-tropic case of HIV-1HXB-2 or in the case of HIV-1Ba-L infecting Supt-1 or PM-1
strains of HIV-1, the expression of CD26 on the cell sur- cells. The infections of H9 and Hut78 cells by HIV-1Ba-L were repeated
twice. Representative data are shown.face is down-regulated at the transcriptional level (Ora-
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clones of PM-1 and the expression of CD26 described
by Oravecz et al. was coincidental. The increased expres-
sion of Mf-tropic HIV-1 seen in these clones is likely
due to other, unknown factors.
Regulation of CD26 expression in PM-1 cells is not
influenced by infection with HIV-1
We observed the expression of CD26 on PM-1 cells
following infection by strains of HIV-1 that differed in their
cellular tropism. The uninfected control cultures showed
considerable fluctuation of CD26 expression. Cultures
infected by the different strains of HIV-1 showed no sig-
nificant differences from levels of CD26 expression seen
in the uninfected controls nor did they demonstrate any
significant differences between the different strains.FIG. 4. Changes in CD26 expression by PM-1 cells for uninfected
These results directly contradict the observations of Ora-cells (half-solid squares, thick line), cells infected with T-cell tropic HIV-
1 (open circles, thin line), and cells infected with Mf-tropic HIV-1 (solid vecz et al. (1995) and we are unable to see an obvious
triangles, dashed line). The data shown are the mean of three determi- explanation. Both reports describe variability of CD26
nations (uninfected cells), eight determinations (T-tropic HIV-1 infected expression by PM-1. Oravecz et al. attribute the down-
cells), or four determinations (Mf-tropic HIV-1 infected cells) for each
regulation of CD26 that they observed to the outgrowthtime point. Error bars represent the standard error of the mean.
of CD26low or CD260 cells in the PM-1 HIV-1Ba-L-infected
cultures. In addition, they used CD26low clones of PM-1
to study the growth of Mf-tropic strains of HIV-1. Sincecreases in CD26 staining, nor was the decline in expres-
the cell line PM-1 was derived as a single clone from cellsion shown to be related to the tropism of the strain of
line Hut78, the isolation of further biologically divergentHIV-1 used, as cells infected with T-cell-tropic strains of
clones from PM-1 might suggest that this cell line isHIV-1 showed similar declines to those infected with Mf-
unstable, making it difficult to obtain consistent, reliabletropic strains of HIV-1 (Fig. 4). From these observations,
results. Our observations of the variability of CD26 couldwe conclude that CD26 expression by cell line PM-1
be variations of the relative growth rates of CD26/ anddoes not seem to be influenced by HIV-1 directly, but
CD260 subpopulations over time or more simply as varia-may be transiently affected by other, unknown factors.
tions of CD26 expression in PM-1 cells in response to
changing culture conditions.DISCUSSION
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